Navigation Links
Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Date:2/19/2008

ASHBURN, Va., Feb. 19 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the second of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections, has commenced dosing.

GENTAMICIN SURGICAL IMPLANT is a fully biodegradable, leave-behind surgical implant impregnated with the broad spectrum aminoglycoside antibiotic, gentamicin. It is designed to provide a high concentration of gentamicin (which has a concentration-dependent mechanism of action) directly to the target tissue for localized action, while maintaining low systemic levels well below the toxicity threshold. The product was developed using Innocoll's proprietary collagen-based drug delivery technology, CollaRx, and (outside of the US) is indicated as an adjunct to systemic antibiotic therapy for the treatment of localized, deep tissue infections and the prevention of surgical site infections in both hard and soft tissues. GENTAMICIN SURGICAL IMPLANT is already approved in 49 countries spanning Europe, Latin America, Middle East, Africa and Asia and there are more than 60 prospective clinical trials and published case reports totaling over 7,500 patients documenting its safety and efficacy over a broad range of orthopedic, colorectal, cardiothoracic, vascular, and neurosurgical procedures.

According to advice from FDA received at both pre-IND and post-IND meetings held in 2007, Innocoll will conduct two multi-centered phase 3 clinical trials in the US to support the planned New Drug Application (NDA). The first trial in cardiac surgery patients at higher risk of surgical site infection commenced in December 2007. The second trial, which has now enrolled its first patient, is in general surgery patients undergoing open colorectal surgery. Innocoll has appointed Duke University's Duke Clinical Research Instit
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
4. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
5. Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
6. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
7. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
10. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
11. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... and BARCELONA , October 31, ... (Multigate) was found to infringe two Australian patents of B. ... sale in Australia safety IV catheters ... in Federal Court of Australia proceeding ... http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed judgment, Multigate ...
(Date:10/31/2014)... 2014 Migranade, Inc. announced today the new ... the 36 million U.S. migraine sufferers November, 2014. The ... the actual cause of migraines and not just the ... the source Migranade is assured to be a game ... is available at http://www.migranade.com and will soon ...
(Date:10/31/2014)... 30, 2014 Electronic prescribing or ... of prescription related information between prescriber, dispenser ... a physician and nurse practitioner to transmit ... error occurs during pharmacy operations. E-Prescribing system ... provides complete medical lists, conducts all security ...
Breaking Medicine Technology:B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2Game Changing Migraine Medication To Be Available November 2014 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Clinical trials in which participants are randomly assigned to different ... conducted correctly, it,s widely accepted by the research community that ... But researchers at the University of Michigan hope to ... patients by investigating the impact of a class of innovative ...
... CRY ), an implantable biological medical device ... BioGlue Surgical Adhesive has received Shonin approval from the ... use in the repair of aortic dissections. ... in Japan for use in this subset of cardiac ...
Cached Medicine Technology:U-M Receives NIH, FDA Grant To Study Adaptive Clinical Trial Design 2CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 2CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 3CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 4CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive 5
(Date:10/31/2014)... Fundraising support for fighting cancer prompts many creative events—the results ... Monday, November 10 in the paramedic garage at Soldiers ... Health (SH) employees and community members will gather together to ... new Cancer Center at SSMH. Three beauticians will be on ... and support to which many who have been touched by ...
(Date:10/31/2014)... Cambridge, Mass. Friday. October 31, 2014 — A ... California, Berkeley, and the University of California, Santa ... Institute (NCI) Cancer Genomics Cloud Pilot contracts with ... enable large-scale analysis of The Cancer Genome Atlas ... and the required computing resources in one cloud ...
(Date:10/31/2014)... 2014 At the start of 2014, ... escaping carbon monoxide poisoning in their homes. Now, as ... one family-owned, Missouri-based heating and cooling company is taking ... families start the home heating season with the assurance ... , Beginning Nov. 1, 2014, E and Q Heating ...
(Date:10/31/2014)... FRIDAY, Oct. 31, 2014 (HealthDay News) -- Sleep apnea may ... as where you parked your car or left your house ... with severe sleep apnea showed that this ability -- called ... eye movement (REM) sleep, even when other stages of sleep ... during which dreams typically occur. "We,ve shown for the ...
(Date:10/31/2014)... device to give cancer researchers an unprecedented microscopic look ... through the body, causing more than 90 percent of ... cells travel, the device could uncover new ways to ... university,s Whiting School of Engineering and its Institute for ... system recently in the journal Cancer Research . ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3
... to Enable System Turn-On At Grand Opening and ... LodgeNet Healthcare, a division of LodgeNet Interactive ... leading provider of interactive patient television solutions, today ... is now serving patients at the Oklahoma Heart ...
... Continuing Care Retirement Community To Be Built on 59-Acre ... BRIARCLIFF MANOR, N.Y., May 19 ... Care Retirement Community (CCRC), announced today that it has ... State Department of Health. The Certificate of Authority, which ...
... Efficient Registration and Revenue Cycle Management ProcessesMOBILE, Ala., ... announced today that it has agreed to partner ... to an SSI product. SSI,s ClickON(R) PREVENT ( ... will be powered by Boston Software Systems, flagship ...
... MetroHealth Wall of Hope and Chris Evert Children,s Hospital ... CareTech Solutions, Inc. ( www.caretechsolutions.com ), ... provider for hospitals and health systems, has been honored ... the 2009 Aster Award ( www.AsterAwards.com ) ...
... 14 European groups, headed by Prof. Nils Brose of the ... million Euro, on behalf of the European Union, to study ... One of the research teams is headed by Prof. Kobi ... Ethology and has been awarded a grant of 600,000 Euro. ...
... Private Equity Firm Augments Team to Support Continued ... May 19 Water Street Healthcare Partners ... health care industry, announced today that it has expanded its ... The firm has appointed Peter Strothman to principal and ...
Cached Medicine News:Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 2Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 3Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 2Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 3Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 2Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 3Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 2Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 3
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
... PowerSuite™ holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
... The OptiMumm™ smoke evacuator ... a complete smoke evacuation ... the AccuVac™ smoke evacuation ... system, and either the ...
Simple, stable knee positioning triangles for lower extremity surgery. The triangles are radiolucent, autoclavable, and use latex-free, sterile, disposable pads....
Medicine Products: